Fibrosis predicts post-surgical risk in aortic stenosis, reinforcing its role in guiding treatment decisions for both sexes.

Varanasi: A team of skilled doctors at the Cardiology department at the Institute of Medical Sciences (IMS), Banaras Hindu ...

Ataciguat, a new drug being studied for aortic valve stenosis, shows promise in slowing disease progression and reducing the ...

A new drug could manage aortic valve stenosis, slowing disease progression and reducing the need for aortic valve surgeries.

An experimental drug being developed by Sanofi significantly curbed progression of aortic valve stenosis, a common heart ...

Health Rounds newsletter excerpt has been corrected to indicate in the headline and the first item of the story that Sanofi ...

The Society for Cardiovascular Angiography & Interventions (SCAI) has published an expert consensus statement that provides ...

Aortic valve stenosis (AVS ... is severe enough for the patient to have a surgical or interventional valve replacement. "This research represents a significant advancement in the treatment ...

Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally. Researchers are exploring the use of a new drug called ataciguat to manage ...

Serious heart problems kept one local senior from dancing with his wife. But thanks to a life-saving procedure at White ...

Previous observational studies have highlighted the advantages of mechanical valves over tissue valves for middle-aged ...

Background: There are insufficient data regarding how to deal with moderate aortic valve (AV) dysfunction during rheumatic mitral valve (MV) surgery. In this study, the clinical outcomes of patients ...